As a model of T2D, we used streptozotocin-nicotinamide (Stz-NA) diabetes, which corresponds to T2D: stable moderate hyperglycemia, insulin resistance, and a slight decrease in insulin. This evidence concerns the gene INS and diabetes mellitus.